Checkpoint Therapeutics (CKPT) Competitor Comparison
We are evaluating the key criteria listed to compare Checkpoint Therapeutics (CKPT) against its competitors in the Biotechnology industry.
Market Capitalization
290 / 368Gross Profits
0 / 278Total Revenue
271 / 300EBITDA
0 / 337Free Cashflow
178 / 352Quick Ratio
354 / 357Earnings per Share
190 / 359Dividend yield
0 / 6Total Cash
348 / 358Performance 3 years
275 / 368Performance 5 years
202 / 368Performance 10 years
253 / 368Linearity 3 years
304 / 368Linearity 5 years
125 / 368Linearity 10 years
225 / 367Total Rank
83 / 368Dividend Rank
24 / 368Valuation Rank
195 / 368Piotroski Rank
267 / 368Muliplier Rank
105 / 368Market Capitalization - CKPT ranking 290 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.